Specialty generics operation
-
BI generics sale
Wednesday | Jul 29 2015Boehringer Ingelheim has confirmed the sale of its US-based Roxane Laboratories specialty generics operation to Hikma.
Boehringer Ingelheim has confirmed the sale of its US-based Roxane Laboratories specialty generics operation to Hikma.
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.